Pharmaq signs financing of leveraged buy-out

Norwegian pharmaceutical company Pharmaq has signed a new Nkr815m ($139.6m) debt package. The senior credit facilities will serve to support private equity firm Permira’s acquisition of Pharmaq, refinance existing debt, and are also for general corporate purposes.